<DOC>
	<DOCNO>NCT00436995</DOCNO>
	<brief_summary>The purpose study assess proportion subject sucessfully achieve mean Hemoglobin great equal 11 g/dL evaluation period follow extension Weekly ( QW ) Once Every Other Week ( Q2W ) Darbepoetin Alfa administraion .</brief_summary>
	<brief_title>Extension From Weekly Once Every Other Week Darbepoetin Alfa Administration Subjects With Chronic Kidney Disease Receiving Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Receiving dialysis 3 month enrollment . The mean 2 screen Hb value take least 7 day appart must great equal 11g/dL less equal 13.0 g/dL Receiving stable QW darbepoetin alfa dose least 6 week enrollment Adequate iron store ( serum ferritin equal great 100 ug/L Uncontrolled hypertension Prior history Cardiovascular Incidents 12 week prior enrollment Other hematological disorder Upper low GI bleed within prior 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Dialysis</keyword>
	<keyword>Anaemia</keyword>
</DOC>